PAPPA and lung carcinoma: For example, it has been shown that murine PAPP-A deficiency results in a delayed occurrence of tumors [31,32]; that PAPP-A level is elevated in lung cancer patients [33] and a prognostic marker in breast cancer [20]; and that PAPP-A is expressed by a wide range of cells of malignant origin [4,15,34].